WP
Waycross Partners’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.4M | Buy |
169,336
+12,050
| +8% | +$2.24M | 2.96% | 13 |
|
|
2025
Q1 | $33M | Buy |
157,286
+22,282
| +17% | +$4.67M | 3.69% | 8 |
|
|
2024
Q4 | $24M | Buy |
135,004
+4,019
| +3% | +$714K | 3.11% | 8 |
|
|
2024
Q3 | $25.9M | Buy |
130,985
+2,718
| +2% | +$537K | 3.58% | 7 |
|
|
2024
Q2 | $22M | Buy |
128,267
+12,086
| +10% | +$2.07M | 3.38% | 8 |
|
|
2024
Q1 | $21.2M | Buy |
116,181
+6,534
| +6% | +$1.19M | 3.64% | 7 |
|
|
2023
Q4 | $17M | Sell |
109,647
-5,102
| -4% | -$791K | 3.19% | 9 |
|
|
2023
Q3 | $17.1M | Buy |
114,749
+4,653
| +4% | +$694K | 3.78% | 6 |
|
|
2023
Q2 | $14.8M | Buy |
110,096
+18,433
| +20% | +$2.48M | 3.22% | 7 |
|
|
2023
Q1 | $14.6M | Buy |
91,663
+17,067
| +23% | +$2.72M | 4.24% | 3 |
|
|
2022
Q4 | $12.1M | Buy |
74,596
+34,641
| +87% | +$5.6M | 4.37% | 3 |
|
|
2022
Q3 | $5.36M | Sell |
39,955
-285
| -0.7% | -$38.2K | 3.61% | 4 |
|
|
2022
Q2 | $6.16M | Buy |
40,240
+2,348
| +6% | +$360K | 4.09% | 3 |
|
|
2022
Q1 | $6.14M | Buy |
37,892
+3,454
| +10% | +$560K | 3.58% | 3 |
|
|
2021
Q4 | $4.66M | Buy |
34,438
+5,200
| +18% | +$704K | 2.67% | 5 |
|
|
2021
Q3 | $3.15M | Sell |
29,238
-27,362
| -48% | -$2.95M | 1.98% | 14 |
|
|
2021
Q2 | $6.38M | Buy |
56,600
+27,611
| +95% | +$3.11M | 3.39% | 6 |
|
|
2021
Q1 | $3.14M | Buy |
28,989
+12,000
| +71% | +$1.3M | 1.75% | 18 |
|
|
2020
Q4 | $1.82M | Buy |
+16,989
| New | +$1.82M | 1.13% | 29 |
|